Informaçao sobre o Autor

Горбунова, В. А

Edição Seção Título Arquivo
Nº 1s (2012) Articles SORAFENIB V LEChENII RASPROSTRANENNOGO GEPATOTsELLYuLYaRNOGO RAKA
Nº 18 (2012) Articles Own experience of use of EGFR tyrosine kinase inhibitors and bevacizumab in the treatment of patients with non-small cell lung cancer
Nº 18 (2012) Articles Herceptin in the treatment of disseminated HER2-positive gastric cancer. Clinical case of successful treatment of elderly patient
Nº 8 (2014) Articles NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Nº 8 (2014) Articles EVEROLIMUS (AFINITOR): NOVYE VOZMOZhNOSTI TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Nº 8 (2015) Articles Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Nº 8 (2016) Articles NEW POTENTIALS FOR THE USE OF SOMATOSTATIN ANALOGS IN NEUROENDOCRINE TUMORS
Nº 17 (2016) Articles THE USE OF SUNITINIB IN PANCREATIC NEUROENDOCRINE TUMORS: EXPERIENCE OF THE DEPARTMENT OF CHEMOTHERAPY FSBI RORC N.A. N.N. BLOKHIN OF RMH
Nº 8 (2017) Articles Cashuistic case of treatment of discemned small-cell lung cancer
Nº 8 (2017) Articles Combined targeted therapy with dabraphenib +trametinib in treatment of melanoma patients with V600 BRAF mutations and brain metastases
Nº 17 (2017) Articles Example of the integrated approach to treatment of the patient with disseminated stomach cancer taking into account of modern clinical trends
Nº 7 (2018) Articles RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
Nº 12 (2018) Articles Neuroendocrine tumors: general characteristics and features of management tactics
Nº 12 (2018) Articles Pharmacotherapy of neuroendocrine tumors
Volume 26, Nº 12 (2019) Articles Neuroendocrine tumors: current changes in the classification, diagnosis and therapy presented in the draft clinical guidelines of the Ministry of Health of the Russian Federation 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies